Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
J. Clin. Oncol 2022 Sep 10;40(26)3047-3056, LM Madanat-Harjuoja, LA Renfro, K Klega, B Tornwall, AR Thorner, A Nag, D Dix, JS Dome, LR Diller, CV Fernandez, EA Mullen, BD CromptonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.